CY1114869T1 - Παραγωγα 5-αμινο-2-(1-υδροξυ-αιθυλο)-τετραϋδροπυρανιου - Google Patents
Παραγωγα 5-αμινο-2-(1-υδροξυ-αιθυλο)-τετραϋδροπυρανιουInfo
- Publication number
- CY1114869T1 CY1114869T1 CY20131101136T CY131101136T CY1114869T1 CY 1114869 T1 CY1114869 T1 CY 1114869T1 CY 20131101136 T CY20131101136 T CY 20131101136T CY 131101136 T CY131101136 T CY 131101136T CY 1114869 T1 CY1114869 T1 CY 1114869T1
- Authority
- CY
- Cyprus
- Prior art keywords
- tethydropyranium
- aythyl
- hydroxy
- amino
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Η εφεύρεση αφορά σε αντιβακτηριακές ενώσεις του τύπου Ι, όπου το R1 παριστάνει αλκοξύ (ειδικά μεθοξύ), το R2 παριστάνει Η ή F, έκαστο από τα R3, R4, R5 και R6 παριστάνει ανεξάρτητα Η ή D, το V παριστάνει CΗ και το W παριστάνει CH ή Ν ή το V παριστάνει Ν και το W παριστάνει CH, το Υ παριστάνει CH ή Ν, το Ζ παριστάνει Ο, S ή CΗ2, και το Α παριστάνει, CΗ2, CH2CH2 ή CD2CD2, και άλατα τέτοιων ενώσεων.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2008055261 | 2008-12-12 | ||
| EP09796819.2A EP2376497B1 (en) | 2008-12-12 | 2009-12-11 | 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1114869T1 true CY1114869T1 (el) | 2016-12-14 |
Family
ID=41723046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131101136T CY1114869T1 (el) | 2008-12-12 | 2013-12-18 | Παραγωγα 5-αμινο-2-(1-υδροξυ-αιθυλο)-τετραϋδροπυρανιου |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8211890B2 (el) |
| EP (1) | EP2376497B1 (el) |
| JP (1) | JP4955835B2 (el) |
| KR (1) | KR101297450B1 (el) |
| CN (1) | CN102232078B (el) |
| AR (1) | AR074604A1 (el) |
| AU (1) | AU2009325902B2 (el) |
| BR (1) | BRPI0924081A2 (el) |
| CA (1) | CA2744456C (el) |
| CL (1) | CL2011001413A1 (el) |
| CY (1) | CY1114869T1 (el) |
| DK (1) | DK2376497T3 (el) |
| ES (1) | ES2435596T3 (el) |
| HK (1) | HK1162478A1 (el) |
| HR (1) | HRP20140010T1 (el) |
| IL (1) | IL213432A (el) |
| MA (1) | MA32956B1 (el) |
| MX (1) | MX2011005905A (el) |
| MY (1) | MY159183A (el) |
| NZ (1) | NZ593891A (el) |
| PL (1) | PL2376497T3 (el) |
| PT (1) | PT2376497E (el) |
| RU (1) | RU2525541C2 (el) |
| SG (1) | SG172088A1 (el) |
| SI (1) | SI2376497T1 (el) |
| TW (1) | TWI426076B (el) |
| WO (1) | WO2010067332A1 (el) |
| ZA (1) | ZA201105095B (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR076222A1 (es) | 2009-04-09 | 2011-05-26 | Actelion Pharmaceuticals Ltd | Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen |
| ES2578182T3 (es) | 2011-05-31 | 2016-07-21 | Actelion Pharmaceuticals Ltd. | Procedimientos de preparación de intermediarios sintéticos que pueden usarse para la fabricación de antibióticos |
| WO2013003383A1 (en) * | 2011-06-27 | 2013-01-03 | Kyorin Pharmaceutical Co., Ltd. | Bridged bicyclic compounds for the treatment of bacterial infections |
| WO2013038374A1 (en) | 2011-09-16 | 2013-03-21 | Actelion Pharmaceuticals Ltd | Process for manufacturing a synthetic intermediate |
| AR089929A1 (es) | 2012-02-10 | 2014-10-01 | Actelion Pharmaceuticals Ltd | Proceso para manufacturar un derivado de naftiridina |
| AR090844A1 (es) | 2012-04-27 | 2014-12-10 | Actelion Pharmaceuticals Ltd | Proceso para elaborar derivados de naftiridina |
| TW201722965A (zh) * | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
| TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
| IL301709A (en) | 2017-08-09 | 2023-05-01 | Denali Therapeutics Inc | Compounds, preparations and methods |
| WO2019046779A1 (en) * | 2017-09-01 | 2019-03-07 | Denali Therapeutics Inc. | COMPOUNDS, COMPOSITIONS AND METHODS |
| JP2022520236A (ja) | 2019-02-13 | 2022-03-29 | デナリ セラピューティクス インコーポレイテッド | 化合物、組成物、及び、方法 |
| MA54959A (fr) | 2019-02-13 | 2021-12-22 | Denali Therapeutics Inc | Composés, compositions et procédés |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1095611A1 (ru) * | 1982-09-10 | 2007-06-27 | Краснодарский ордена Трудового Красного Знамени политехнический институт | Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью |
| CA2195129C (en) * | 1991-03-28 | 2002-09-10 | Anabella Villalobos | Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
| GB9822450D0 (en) | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
| GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| AR038240A1 (es) * | 2002-01-29 | 2005-01-05 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion |
| TW200409637A (en) * | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
| AR042486A1 (es) * | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion . |
| DE10316081A1 (de) | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| JP2008505920A (ja) | 2004-07-08 | 2008-02-28 | グラクソ グループ リミテッド | 抗菌剤 |
| JP4887297B2 (ja) * | 2004-09-24 | 2012-02-29 | アクテリオン ファーマシューティカルズ リミテッド | 新規二環式抗生物質 |
| JP5314244B2 (ja) | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | 新規な含窒素複素環化合物およびその塩 |
| AU2006250987A1 (en) * | 2005-05-24 | 2006-11-30 | Astrazeneca Ab | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| WO2007016610A2 (en) * | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | Antibacterial agents |
| EA200801128A1 (ru) | 2005-10-21 | 2008-10-30 | Глэксо Груп Лимитед | Пери-конденсированные трициклические соединения, полезные в качестве антибактериальных средств |
| WO2007071936A1 (en) | 2005-12-22 | 2007-06-28 | Glaxo Group Limited | Heterocyclic compounds, their preparation and their use as antibacterials |
| DE102005062889A1 (de) | 2005-12-29 | 2007-07-05 | Robert Bosch Gmbh | Elektrische Null-Kraft-Steckvorrichtung |
| ES2376488T3 (es) * | 2006-01-26 | 2012-03-14 | Actelion Pharmaceuticals Ltd. | Antibióticos de tetrahidropirano. |
| CA2643962A1 (en) * | 2006-03-10 | 2007-09-20 | Actelion Pharmaceuticals Ltd | Antibiotic compounds |
| DE602007009205D1 (de) | 2006-04-06 | 2010-10-28 | Glaxo Group Ltd | Pyrrolochinoxalinonderivate als antibakterielle mittel |
| GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
| EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
| CL2008001003A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| BRPI0812942B1 (pt) * | 2007-06-15 | 2018-11-21 | Actelion Pharmaceuticals Ltd | composto derivado de 3-amino-6 - (1-amino-etil) - tetra-hidropirano, composição farmacêutica e uso de referido composto. |
| US8354426B2 (en) | 2007-11-26 | 2013-01-15 | Toyama Chemical Co., Ltd. | Naphthyridine derivative monohydrate and method for producing the same |
-
2009
- 2009-12-11 AU AU2009325902A patent/AU2009325902B2/en not_active Ceased
- 2009-12-11 TW TW098142582A patent/TWI426076B/zh not_active IP Right Cessation
- 2009-12-11 ES ES09796819T patent/ES2435596T3/es active Active
- 2009-12-11 DK DK09796819.2T patent/DK2376497T3/da active
- 2009-12-11 EP EP09796819.2A patent/EP2376497B1/en active Active
- 2009-12-11 US US13/139,179 patent/US8211890B2/en not_active Expired - Fee Related
- 2009-12-11 CA CA2744456A patent/CA2744456C/en active Active
- 2009-12-11 WO PCT/IB2009/055689 patent/WO2010067332A1/en active Application Filing
- 2009-12-11 CN CN200980148242.2A patent/CN102232078B/zh active Active
- 2009-12-11 SI SI200930791T patent/SI2376497T1/sl unknown
- 2009-12-11 MY MYPI2011002646A patent/MY159183A/en unknown
- 2009-12-11 AR ARP090104821A patent/AR074604A1/es not_active Application Discontinuation
- 2009-12-11 MX MX2011005905A patent/MX2011005905A/es active IP Right Grant
- 2009-12-11 PL PL09796819T patent/PL2376497T3/pl unknown
- 2009-12-11 SG SG2011042611A patent/SG172088A1/en unknown
- 2009-12-11 KR KR1020117015370A patent/KR101297450B1/ko active IP Right Grant
- 2009-12-11 BR BRPI0924081A patent/BRPI0924081A2/pt active Search and Examination
- 2009-12-11 MA MA34003A patent/MA32956B1/fr unknown
- 2009-12-11 PT PT97968192T patent/PT2376497E/pt unknown
- 2009-12-11 RU RU2011128550/04A patent/RU2525541C2/ru not_active IP Right Cessation
- 2009-12-11 NZ NZ593891A patent/NZ593891A/xx not_active IP Right Cessation
- 2009-12-11 JP JP2011540318A patent/JP4955835B2/ja active Active
-
2011
- 2011-06-09 IL IL213432A patent/IL213432A/en not_active IP Right Cessation
- 2011-06-10 CL CL2011001413A patent/CL2011001413A1/es unknown
- 2011-07-11 ZA ZA2011/05095A patent/ZA201105095B/en unknown
-
2012
- 2012-03-16 HK HK12102672.7A patent/HK1162478A1/xx not_active IP Right Cessation
-
2013
- 2013-12-18 CY CY20131101136T patent/CY1114869T1/el unknown
-
2014
- 2014-01-07 HR HRP20140010AT patent/HRP20140010T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1114869T1 (el) | Παραγωγα 5-αμινο-2-(1-υδροξυ-αιθυλο)-τετραϋδροπυρανιου | |
| CY1123333T1 (el) | Παραγωγα ινδολινονης και διαδικασια για την παραγωγη τους | |
| ECSP099091A (es) | Profarmaco de compuesto de cinamida | |
| CY1114452T1 (el) | Ενωσεις πυρρολιου | |
| CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
| CY1118435T1 (el) | Παραγωγο μορφολινο νουκλεϊνικου οξεος | |
| CY1116945T1 (el) | Παραγωγα ινδολιζινης, διεργασια για την παρασκευη αυτης και θεραπευτικη χρηση αυτης | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| CY1117142T1 (el) | Παραγωγο αμινοπυραζολης | |
| ECSP099818A (es) | Procesos para la preparacion de pirazoles | |
| CY1119423T1 (el) | Παραγωγο κυκλοαλκυλ-υποκατεστημενης ιμιδαζολης | |
| CY1120477T1 (el) | Ενεργοποιητης του υποδοχεα που ενεργοποιειται απο πολλαπλασιαστες των υπεροξεισωματων | |
| CY1112780T1 (el) | Νεα σουλφονυλοπυρρολια ως αναστολεις της ηdac | |
| CY1110489T1 (el) | Παραγωγα ισοκινολινης | |
| CY1112914T1 (el) | Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης | |
| CR10662A (es) | Compuestos de metilpiridopirimidinona | |
| CY1116540T1 (el) | Μεθοδος παραγωγης 2'-δεοξυ-5-αζακυτιδινης (δεσιταβινη) | |
| CY1117862T1 (el) | Ετεροκυκλικες ενωσεις βενζοδιοξολιου ή βενζοδιοξεπινης ως αναστολεις φωσφοδιεστερασης | |
| UA117151C2 (uk) | N-ациліміногетероциклічні сполуки | |
| CY1112520T1 (el) | Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
| CY1121626T1 (el) | Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου | |
| CO6341610A2 (es) | Compuesto heterociclilo aromatico que contiene nitrogeno. | |
| CY1111748T1 (el) | Παραγωγα 7-αλκυνυλο-1.8-ναφθυριδονων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη |